Mast cell-associated TNF promotes dendritic cell migration

Journal of Immunology

Volumn 176, Issue 7, 2006, Pages 4102-4112

  Suto, Hajime ^a,b   Nakae, Susumu ^a   Kakurai, Maki ^a   Sedgwick, Jonathon D ^c,d   Tsai, Mindy ^a   Galli, Stephen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JUNTENDO UNIVERSITY   (Japan)

^c MERCK RESEARCH LABORATORIES   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; PICRYL CHLORIDE; TUMOR NECROSIS FACTOR; CORTICOSTEROID; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL MIGRATION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; GENE MUTATION; IN VIVO STUDY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SKIN CELL; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; CHEMISTRY; CONTACT DERMATITIS; CYTOLOGY; DRUG EFFECT; GENETICS; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LYMPH NODE; METABOLISM; MOUSE MUTANT; PATHOLOGY; TIME;

ADMINISTRATION, INTRANASAL; ADRENAL CORTEX HORMONES; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; DERMATITIS, CONTACT; FLUORESCEIN-5-ISOTHIOCYANATE; LYMPH NODES; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646062612     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.7.4102     Document Type: Article

References (69)

1. Grabbe, S., and T. Schwarz. 1998. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 19: 37-44.
2. Steinman, R. M., M. Pack, and K. Inaba. 1997. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156: 25-37.
3. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhe, P. Perrin, N. Romani, C. H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654.
4. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNFα-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184: 1397-1411.
5. + T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Int. Immunol. 16: 685-695.
6. Yokozeki, H., M. Ghoreishi, S. Takagawa, K. Takayama, T. Satoh, I. Katayama, K. Takeda, S. Akira, and K. Nishioka. 2000. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J. Exp. Med. 191: 995-1004.
7. Cumberbatch, M., R. J. Dearman, C. E. Griffiths, and I. Kimber. 2000. Langerhans cell migration. Clin. Exp. Dermatol. 25: 413-418.
8. Wang, B., L. Zhuang, H. Fujisawa, G. A. Shinder, C. Feliciani, G. M. Shivji, H. Suzuki, P. Amerio, P. Toto, and D. N. Sauder. 1999. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J. Immunol. 162: 277-283.
9. Nakae, S., Y. Komiyama, S. Narumi, K. Sudo, R. Horai, Y. Tagawa, K. Sekikawa, K. Matsushima, M. Asano, and Y. Iwakura. 2003. IL-1-induced tumor necrosis factor-α elicits inflammatory cell infiltration in the skin by inducing IFN-γ-inducible protein 10 in the elicitation phase of the contact hypersensitivity response. Int. Immunol. 15: 251-260.
10. Gordon, J. R., and S. J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346: 274-276.
11. Gordon, J. R., and S. J. Galli. 1991. Release of both preformed and newly synthesized tumor necrosis factor α (TNF-α)/cachectin by mouse mast cells stimulated via the FcεRI: a mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J. Exp. Med. 174: 103-107.
12. Askenase, P. W., H. Van Loveren, S. Kraeuter-Kops, Y. Ron, R. Meade, T. C. Theoharides, J. J. Nordlund, H. Scovern, M. D. Gerhson, and W. Ptak. 1983. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J. Immunol. 131: 2681-2694.
13. Biedermann, T., M. Kneilling, R. Mailhammer, K. Maier, C. A. Sander, G. Kollias, S. L. Kunkel, L. Hultner, and M. Rocken. 2000. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192: 1441-1452.
14. Bryce, P. J., M. L. Miller, I. Miyajima, M. Tsai, S. J. Galli, and H. C. Oettgen. 2004. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 20: 381-392.
15. Jawdat, D. M., E. J. Albert, G. Rowden, I. D. Haidl, and J. S. Marshall. 2004. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J. Immunol. 173: 5275-5282.
16. Korner, H., M. Cook, D. S. Riminton, F. A. Lemckert, R. M. Hoek, B. Ledermann, F. Kontgen, B. Fazekas de St. Groth, and J. D. Sedgwick. 1997. Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 21: 2600-2609.
17. Ruuls, S. R., R. M. Hoek, V. N. Ngo, T. McNeil, L. A. Lucian, M. J. Janatpour, H. Korner, H. Scheerens, E. M. Hessel, J. G. Cyster, et al. 2001. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 15: 533-543.
18. Duttlinger, R., K. Manova, T. Y. Chu, C. Gyssler, A. D. Zelenetz, R. F. Bachvarova, and P. Besmer. 1993. W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. Development 118: 705-717.
19. Nakae, S., C. Naruse-Nakajima, K. Sudo, R. Horai, M. Asano, and Y. Iwakura. 2001. IL-1α, but not IL-1β, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity. Int. Immunol. 13: 1471-1478.
20. Lutz, M. B., C. U. Assmann, G. Girolomoni, and P. Ricciardi-Castagnoli. 1996. Different cytokines regulate antigen uptake and presentation of a precursor dendritic cell line. Eur. J. Immunol. 26: 586-594.
21. Vermaelen, K. Y., I. Carro-Muino, B. N. Lambrecht, and R. A. Pauwels. 2001. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 193: 51-60.
22. Grabbe, S., K. Steinbrink, M. Steinert, T. A. Luger, and T. Schwarz. 1995. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J. Immunol. 155: 4207-4217.
23. Chensue, S. W., N. W. Lukacs, T. Y. Yang, X. Shang, K. A. Frait, S. L. Kunkel, T. Kung, M. T. Wiekowski, J. A. Hedrick, D. N. Cook, et al. 2001. Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice. J. Exp. Med. 193: 573-584.
24. Tang, A., M. Amagai, L. G. Granger, J. R. Stanley, and M. C. Udey. 1993. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361: 82-85.
25. Pior, J., T. Vogl, C. Sorg, and E. MacHer. 1999. Free hapten molecules are dispersed by way of the bloodstream during contact sensitization to fluorescein isothiocyanate. J. Invest. Dermatol. 113: 888-893.
26. W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167: 835-848.
27. W-sh sash mice. Clin. Exp. Allergy 35: 82-88.
28. Galli, S. J., S. Nakae, and M. Tsai. 2005. Mast cells in the development of adaptive immune responses. Nat Immunol. 6: 135-142.
29. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. Williams, and M. Tsai. 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23: 749-786.
30. Tsai, M., M. A. Grimbaldeston, M. Yu, S. Y. Tam, and S. J. Galli. 2005. Using mast cell knock-in mice to analyze the roles of mast cells in allergic responses in vivo. Chem. Immunol Allergy 87: 179-197.
31. Bazzoni, F., and B. Beutler. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334: 1717-1725.
32. Galli, S. J., and I. Hammel. 1984. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science 226: 710-713.
33. d mice. J. Immunol. 135: 879-885.
34. Nussenzweig, M. C., R. M. Steinman, M. D. Witmer, and B. Gutchinov. 1982. A monoclonal antibody specific for mouse dendritic cells. Proc. Natl. Acad. Sci. USA 79: 161-165.
35. Martin, T. R., T. Takeishi, H. R. Katz, K. F. Austen, J. M. Drazen, and S. J. Galli. 1993. Mast cell activation enhances airway responsiveness to methacholine in the mouse. J. Clin. Invest. 91: 1176-1182.
36. Williams, C. M., and S. J. Galli. 2000. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med. 192: 455-462.
37. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381: 77-80.
38. McLachlan, J. B., J. P. Hart, S. V. Pizzo, C. P. Shelburne, H. F. Staats, M. D. Gunn, and S. N. Abraham. 2003. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat. Immunol. 4: 1199-1205.
39. Wershil, B. K., Z. S. Wang, J. R. Gordon, and S. J. Galli. 1991. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent: partial inhibition of the reaction with antiserum against tumor necrosis factor-α. J. Clin. Invest. 87: 446-453.
40. Kawakami, T., and S. J. Galli. 2002. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2: 773-786.
41. Mekori, Y. A., and D. D. Metcalfe. 2000. Mast cells in innate immunity. Immunol. Rev. 173: 131-140.
42. Caron, G., Y. Delneste, E. Roelandts, C. Duez, N. Herbault, G. Magistrelli, J. Y. Bonnefoy, J. Pestel, and P. Jeannin. 2001. Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J. Immunol. 166: 6000-6006.
43. Mazzoni, A., H. A. Young, J. H. Spitzer, A. Visintin, and D. M. Segal. 2001. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J. Clin. Invest. 108: 1865-1873.
44. 2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9: 744-749.
45. Stoitzner, P., G. Ratzinger, F. Koch, K. Janke, T. Scholler, A. Kaser, H. Tilg, W. W. Cruikshank, P. Fritsch, and N. Romani. 2001. Interleukin-16 supports the migration of Langerhans cells, partly in a CD4-independent way. J. Invest. Dermatol. 116: 641-649.
46. Demeure, C. E., K. Brahimi, F. Hacini, F. Marchand, R. Peronet, M. Huerre, P. St-Mezard, J. F. Nicolas, P. Brey, G. Delespesse, and S. Mecheri. 2005. Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J. Immunol. 174: 3932-3940.
47. Chun, K. H., Y. Imai, N. Higashi, and T. Irimura. 2000. Migration of dermal cells expressing a macrophage C-type lectin during the sensitization phase of delayed-type hypersensitivity. J. Leukocyte Biol. 68: 471-478.
48. 2+ response of RBL-2H3 mast cells. Immunol. Lett. 80: 119-124.
49. Echtenacher, B., D. N. Mannel, and L. Hultner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381: 75-77.
50. Prodeus, A. P., X. Zhou, M. Maurer, S. J. Galli, and M. C. Carroll. 1997. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 390: 172-175.
51. Maurer, M., B. Echtenacher, L. Hultner, G. Kollias, D. N. Mannel, K. E. Langley, and S. J. Galli. 1998. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J. Exp. Med. 188: 2343-2348.
52. von Stebut, E., M. Metz, G. Milon, J. Knop, and M. Maurer. 2003. Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1α/β released from neutrophils recruited by mast cell-derived TNFα. Blood 101: 210-215.
53. Watanabe, N., B. Akikusa, S. Y. Park, H. Ohno, L. Fossati, G. Vecchietti, J. E. Gessner, R. E. Schmidt, J. S. Verbeek, B. Ryffel, et al. 1999. Mast cells induce autoantibody-mediated vasculitis syndrome through tumor necrosis factor production upon triggering Fcγ receptors. Blood 94: 3855-3863.
54. Feldmann, M., and R. N. Maini. 2003. Lasker clinical medical research award: TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat. Med. 9: 1245-1250.
55. Papadakis, K. A., and S. R. Targan. 2000. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 51: 289-298.
56. Babu, K. S., D. E. Davies, and S. T. Holgate. 2004. Role of tumor necrosis factor α in asthma. Immunol. Allergy Clin. North Am. 24: 583-597, v-vi.
57. Bradding, P., J. A. Roberts, K. M. Britten, S. Montefort, R. Djukanovic, R. Mueller, C. H. Heusser, P. H. Howarth, and S. T. Holgate. 1994. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10: 471-480.
58. Beil, W. J., P. F. Weller, M. A. Peppercorn, S. J. Galli, and A. M. Dvorak. 1995. Ultrastructural immunogold localization of subcellular sites of TNF-α in colonic Crohn's disease. J. Leukocyte Biol. 58: 284-298.
59. Koshino, T., Y. Arai, Y. Miyamoto, Y. Sano, M. Itami, S. Teshima, K. Hirai, T. Takaishi, K. Ito, and Y. Morita. 1996. Airway basophil and mast cell density in patients with bronchial asthma: relationship to bronchial hyperresponsiveness. J. Asthma 33: 89-95.
60. Denburg, J. A. 1998. Basophils and mast cells in airway inflammation and asthma. Can. Respir. J. 5(Suppl. A): 41A-44A.
61. Lilja, I., C. Gustafson-Svard, L. Franzen, and R. Sjodahl. 2000. Tumor necrosis factor-α in ileal mast cells in patients with Crohn's disease. Digestion 61: 68-76.
62. Furusu, H., K. Murase, Y. Nishida, H. Isomoto, F. Takeshima, Y. Mizuta, B. R. Hewlett, R. H. Riddell, and S. Kohno. 2002. Accumulation of mast cells and macrophages in focal active gastritis of patients with Crohn's disease. Hepatogastroenterology 49: 639-643.
63. Brightling, C. E., P. Bradding, F. A. Symon, S. T. Holgate, A. J. Wardlaw, and I. D. Pavord. 2002. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346: 1699-1705.
64. Nigrovic, P. A., and D. M. Lee. 2005. Mast cells in inflammatory arthritis. Arthritis Res. Ther. 7: 1-11.
65. Juurikivi, A., C. Sandler, K. A. Lindstedt, P. T. Kovanen, T. Juutilainen, M. J. Leskinen, T. Maki, and K. K. Eklund. 2005. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis. Ann. Rheum. Dis. 64: 1126-1131.
66. Cumberbatch, M., and I. Kimber. 1995. Tumour necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 84: 31-35.
67. Piguet, P. F., G. E. Grau, C. Hauser, and P. Vassalli. 1991. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J. Exp. Med 173: 673-679.
68. 2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J. Exp. Med. 193: 1135-1147.
69. 2 inhibits airway dendritic cell migration and function in steady-state conditions by selective activation of the D prostanoid receptor 1. J. Immunol. 171: 3936-3940.